For this Roundtable Discussion, we have a collection of experts to discuss the management of an adult patient with failed Fontan circulation presenting for a Fontan procedure revision. Our panel consists of 4 congenital cardiac anesthesiologists and 1 pediatric cardiothoracic surgeon. Thomas M. Burch, MD, is an assistant professor in cardiac anesthesia at Boston Children's Hospital and is board certified in anesthesiology. His interests include adult and pediatric cardiothoracic anesthesiology and echocardiography as well as e-learning for board review.
(HLHS), specifically mitral stenosis and aortic atresia, which was palliated in the neonatal period with a Norwood procedure and modified Blalock-Taussig shunt (mBTS). At 8 months of age, he had a hemi-Fontan procedure with takedown of the mBTS, and completion of the Fontan circuit at the age of 3. He was lost to follow-up for many years but re-presented about 5 years ago with increasing breathlessness (NYHA class III), cyanosis, syncopal episodes, and abdominal distension. Pulse oximetry showed a room air oxygen saturation of 88%. His echocardiogram showed frequent atrial extrasystoles, and his transthoracic echocardiography showed a morphological right ventricle with mild tricuspid regurgitation and moderately impaired systolic function. It also appeared to show a dilated lateral tunnel with sluggish flow and partial obstruction by thrombus.
Based on these findings, he underwent cardiac catheterization. This confirmed the echocardiography findings and in addition showed several systemic-pulmonary venous collateral vessels, a small restrictive baffle fenestration, and a severe focal stenosis of his right pulmonary artery. His ejection fraction was 42%, and his right ventricular end-diastolic pressure was 12 mm Hg. His systemic venous (Fontan) pressure was 23 mm Hg. His Qp:Qs was calculated at 0.71:1. At the same admission, an implantable cardiac defibrillator (ICD) was implanted.
Questions

What physiological conditions are desirable for a successful Fontan circulation?
Dr Baum: The anatomic and physiologic requirements for a successful Fontan operation have been established over the 4 decades since the operation was first proposed by Fontan and Baudet, and they are generally widely accepted.
1 Since there will be no subpulmonary ventricle supplying blood to the pulmonary circulation, everything needs to be optimal to allow the central venous pressure to be an adequate driving force.
For a patient to be considered a good Fontan candidate, the pulmonary arterial pressure must be low (<15 mm Hg, low risk; 15-20, medium risk; >20, high risk), the transpulmonary gradient needs to be low (<7 mm Hg, low risk; 7-12, medium risk; >12, high risk), the pulmonary arteries need to be of adequate size or only slightly small, and there must be good systolic and diastolic function of the systemic ventricle (end-diastolic pressure <6 mm Hg, low risk; 6-12, moderate risk; >12, high risk). In addition to these risk factors, significant valve incompetence is a risk factor. Non-sinus rhythm would also be considered a risk factor for poor outcome.
How has the surgical implementation of the Fontan circulation evolved since its original description?
Dr Guleserian: Surgical procedures to achieve the "Fontan circulation" have evolved over the past several decades to overcome the absence of 2 distinct ventricular chambers. Chronic elevation of right atrial and vena caval pressure in concert with the absence of a dedicated power source to serve the pulmonary circulation are inherent to Fontan circulation; thus, as discussed by Dr Baum, low pulmonary vascular resistance and optimal systemic ventricular function are essential to achieving successful Fontan circulation.
The traditional Fontan procedure, originally designed for tricuspid atresia and the single left ventricle in 1971 by Drs Frances Fontan and Eugene Baudet, is no longer considered a surgical option today. 1 Modifications to the original atriopulmonary connections have extended repairs to include patients with complex ventricular anatomy and are now most commonly performed for single right ventricular anatomy associated with HLHS or its variants. The modified Fontan procedure using either a lateral tunnel or extracardiac approach (with or without fenestration) is currently performed although the selected approach is often institutionally dependent. Together with improved perioperative management, creation of the Fontan circulation in 2 stages (superior cavopulmonary anastomosis or bidirectional Glenn shunt followed by later Fontan completion), and performance of Fontan procedures at a younger age, have led to reduced operative mortality associated with the Fontan procedure of ≤5% (compared with 15% to 30% in earlier decades), with the current survival of 85% at 20 years. 2 
What potential benefits would revision his Fontan offer?
Dr Guleserian: Over the past 2 decades, survivors of the original atriopulmonary Fontan and those now surviving after the modified Fontan procedures have presented significant management challenges due to the inevitable sequelae of the Fontan circulation. Chronic venous congestion and progressively declining functional status, as evident in this patient and many others, often results in growth failure, progressive cyanosis, persistent effusions, Fontan pathway obstruction, atrioventricular valve dysfunction, atrial tachyarrhythmias, and protein-losing enteropathy.
Although a mild degree of desaturation is present in most Fontan patients, due to coronary sinus drainage to the left atrium or pulmonary shunting, resting saturations <90% suggest the presence of right-to-left shunting (either intracardiac or as a result of veno-venous collateral flow to the left atrium) or development of pulmonary arteriovenous fistulae. In this patient, balloon dilation/ stenting of the stenotic right pulmonary artery, coil embolization of collaterals, or catheter-based occlusion of any residual atrial septal defect/baffle leak may improve saturations and ventricular function and reduce Fontan pressures and ascites making him a more suitable candidate for Fontan conversion. Given his likely high pulmonary vascular resistance (PVR) with a transpulmonary gradient of 11 and Qp:Qs 0.7, aggressive pulmonary vasodilator therapy should be undertaken. Otherwise, heart transplantation should be considered. Obvious transplant concerns in this patient are possible noncompliance, potentially elevated panel reactive antibodies from prior surgical palliation/blood product exposure, and elevated PVR.
Fontan conversion to a total extracardiac cavopulmonary anastomosis with concomitant arrhythmia surgery (modified right atrial Maze) is most commonly performed in those with existing atriopulmonary Fontan connections, although it has been undertaken in those with various iterations of the lateral tunnel approach. Those with presence of giant right atrial thrombus, arrhythmias refractory to medical or simple electrophysiologic treatment, pulmonary venous obstruction by an enlarged right atrium, and ventricular dysfunction from coronary sinus hypertension in the setting of preserved ventricular function are candidates for conversion, whereas those with intrinsic myocardial dysfunction, protein-losing enteropathy (PLE), or multisystem disease are poor candidates and are best referred for heart transplantation. Suitable candidates with failing Fontan physiology and irreversible hepatic dysfunction require combined heart-liver transplantation.
Would transplantation be a better option?
Dr Guleserian: For this particular patient, transplantation would be the better option without improvement in Fontan pressures, saturations, ascites, ventricular function after repeat cardiac catheterization (addressing his right pulmonary artery stenosis and collaterals) in conjunction with pulmonary vasodilator therapy or if he is found to have PLE. Early operative mortality for Fontan patients undergoing cardiac transplantation has been reported up to 35%, much higher than that reported for other forms of congenital heart disease, although the most recent studies have showed no significant difference in early mortality among Fontan patients. 3 Risk factors for poor posttransplant outcomes in the Fontan patient population include increased sensitization rates >10%, with preformed antibodies to donor human leukocyte antigens (HLA), complex systemic/pulmonary venous anatomy, malnutrition associated with PLE, and acute allograft right ventricular dysfunction. Given the significant waitlist mortality, there is increasing interest in the use of mechanical assist devices in Fontan patients as either a bridge to transplantation or as "destination therapy."
What are the main considerations for a Fontan patient undergoing any surgical procedure?
Dr Burch: Considerations for any patient with Fontan physiology scheduled to undergo a surgical procedure include attempting to find the answers to the following questions:
A. Is the surgery emergent, urgent, or elective? If emergent, and it needs to go ASAP then things become pretty simple. Resource recruitment becomes a big priority. The correct personnel, equipment, blood products, monitoring devices, and contingency plans need to be established immediately. Ordering extensive time-consuming tests, especially if they will not drastically alter management, should be discouraged in favor of treating the emergent condition. 4 assure things go as seamlessly as possible? A frank preoperative discussion with the proceduralist regarding the expected degree of surgicalinduced trauma should occur. Expected blood loss, duration of anesthesia, surgical contingency plans, and possible options to limit patient risk need to be evaluated. Given the fragility of these patients, having the most experienced providers performing invasive procedures seems prudent. Equipment, supplies, and contingency plans should be reviewed prior to the patient entering the room.
What are the likely intraoperative problems that will be encountered by this patient during this procedure?
Dr Wesley: This young man has many of the typical manifestations found in patients with a failing Fontan circulation including poor systolic function, elevated Fontan and RV end diastolic pressures, and atrial arrhythmias. He also has abdominal distension, which makes ventilation more difficult and may indicate decreased liver function.
Likely intraoperative anesthetic problems include hypotension, unstable arrhythmias, significant bleeding, and possible problems with cardiopulmonary bypass flow. The combination of moderately depressed RV function and elevated Fontan pressure make these patients susceptible to hypotension from a decrease in contractility, hypovolemia, or other causes of decreased blood flow through the Fontan. Induction of general endotracheal anesthesia with administration of cardiac depressant medications and conversion to positive pressure ventilation often results in decreased contractility and decreased pulmonary blood flow secondary to increased mean airway pressure. The use of muscle relaxant also causes decreased skeletal muscle tone and venous pooling, resulting in a further decrease in venous return. Strategies that should be considered to mitigate hypotension include holding angiotensin-converting enzyme (ACE) inhibitors on the day of surgery, replacing the NPO fluid deficit preoperatively, and starting an inotrope such as dopamine or epinephrine at induction. Ventilation goals should include maintaining low PVR and mean airway pressures. This can be accomplished by using larger tidal volumes (10 cc/kg), low respiratory rate, and an I:E ratio of 1:2-1:3. In addition, several systemic to pulmonary venous collaterals were found in the cath lab. If these were not occluded, CPB may be complicated by hypotension and poor operating conditions.
How should his ICD be managed in the perioperative period?
Dr Wesley: This patient also has a history of atrial arrhythmias and syncopal episodes that have necessitated placement of an automatic ICD (AICD). The AICD will need to be turned off prior to the start of the surgery and defibrillator pads placed. He is at a high risk of developing rapid hemodynamic compromise with loss of sinus rhythm. Immediate cardioversion or defibrillation will likely be needed for treatable arrhythmias. In addition, antiarrhythmic medications may be necessary for recurrent arrhythmias. It may be beneficial to have the electrophysiologist make treatment recommendations when they turn off the AICD.
Dr Pitkin: As Dr Wesley states, the presence of the AICD in this patient needs to be addressed perioperatively. Specifically, during any form of surgery requiring electrocautery, the defibrillation and antitachycardia pacing (ATP) functions should be disabled as the device will be unable to distinguish between the electromagnetic interference (EMI) generated by electrocautery and a true tachyarrhythmia. In addition, the EMI will inhibit any synchronous (demand) pacing function of the ICD resulting in potentially dangerous bradycardia or asystole depending on the degree of underlying sinus node dysfunction. Another consideration is that the ICD electrodes will have almost certainly not been placed by the conventional transvenous route 7 and their extravascular course may render them prone to damage during sternal reentry and mediastinal dissection. Some epicardial leads are unipolar and therefore more sensitive to EMI than bipolar leads. The ICD should therefore be interrogated to find out the underlying cardiac rhythm and reprogrammed to disable defibrillation and ATP functions. Adhesive external defibrillation electrodes ("redo pads") should be placed until these functions have been restored. The pacing function of the ICD should be set at an appropriate rate in an asynchronous (DOO) mode if there is any doubt about underlying sinus node function, since EMI from electrocautery is liable to inhibit pacing in an asynchronous mode. 8 
How should his anticoagulant medication be managed in the perioperative period?
Dr Wesley: Perioperative management of anticoagulants can certainly present a management challenge in Fontan patients. This patient already has a clot in the lateral tunnel. In the postoperative period, patients with a Fontan are hypercoagulable. 9 Careful intraoperative and perioperative management is important to avoid ongoing blood loss without contributing to the postoperative tendency for thrombus formation.
Dr Pitkin: The chronic elevation of systemic venous pressure, which is an intrinsic component of the Fontan circulation, frequently causes abnormalities of liver function as previously mentioned by Dr Guleserian. Alteration in hepatic synthesis of enzymes involved in coagulation may result in both procoagulant (eg, protein S and protein C deficiency) and anticoagulant abnormalities. The high systemic venous pressure may also result in dilation of the systemic venous to pulmonary pathway ("Fontan circuit") with consequent stasis and thrombus formation 10 and may also contribute to the high frequency of atrial dysrhythmias seen in this patient population. 11 The use of platelet inhibitors such as aspirin or full anticoagulation with warfarin is common.
Management of anticoagulation perioperatively is also a difficult question. As Dr Wesley points out, our patient already has some thrombus in his Fontan circuit with the consequent potential for embolization into the pulmonary arteries, a known complication with Fontan patients. 12 A reasonable approach might be to discontinue the warfarin a number of days preoperatively and maintain anticoagulation with either intravenous unfractionated heparin or intermittent doses of low-molecular-weight heparin until the day of surgery. Whatever strategy is chosen, his deficiency in vitamin K-dependent coagulation factors is likely to persist for some time and contribute to the intraoperative coagulopathy.
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